Mivacurium

Mivacurium: An Advanced Review

Mivacurium is a short-acting, non-depolarising neuromuscular blocking agent (NMBA) belonging to the benzylisoquinolinium class. It exerts its pharmacological action by competitively antagonising acetylcholine at nicotinic receptors within the neuromuscular junction, thereby inhibiting synaptic transmission and inducing skeletal muscle relaxation. Its clinical utility is underscored by its favourable pharmacokinetic profile, which includes rapid onset and brief duration of action, making it particularly advantageous in procedures necessitating transient neuromuscular blockade.

Image source Google

Vecuronium

Vecuronium: An Advanced Review of a Neuromuscular Blocking Agent

Vecuronium is a widely utilised aminosteroid-derived neuromuscular blocking agent (NMBA) classified as a non-depolarising muscle relaxant. By competitively antagonising nicotinic acetylcholine receptors at the neuromuscular junction, it induces reversible skeletal muscle paralysis, making it indispensable in anaesthetic and critical care settings. The agent's pharmacological profile ensures its role in facilitating endotracheal intubation, optimising mechanical ventilation, and enabling precise skeletal muscle relaxation during surgical interventions.

Image source Google